Segmental arterial mediolysis: a precursor to fibromuscular dysplasia?
RE Slavin, K Saeki, B Bhagavan… - Modern pathology: an …, 1995 - europepmc.org
We describe five cases of segmental arterial mediolysis (SAM), formerly known as segmental
mediolytic arteritis. SAM occurs in epicardial coronary arteries and in the abdominal …
mediolytic arteritis. SAM occurs in epicardial coronary arteries and in the abdominal …
Structure–activity relationship of human GLO I inhibitory natural flavonoids and their growth inhibitory effects
R Takasawa, S Takahashi, K Saeki, S Sunaga… - Bioorganic & medicinal …, 2008 - Elsevier
Glyoxalase I (GLO I) is the rate-limiting enzyme for detoxification of methylglyoxal (MG), a side
product of glycolysis, which is able to induce apoptosis. Since GLO I is known to be highly …
product of glycolysis, which is able to induce apoptosis. Since GLO I is known to be highly …
[HTML][HTML] Efficacy and safety of adjunctive perampanel in adolescent patients with epilepsy: post hoc analysis of six randomized studies
JE Piña-Garza, W Rosenfeld, K Saeki, V Villanueva… - Epilepsy & Behavior, 2020 - Elsevier
Objective This post hoc analysis of six randomized, double-blind, Phase II and III studies
evaluated efficacy and safety of adjunctive perampanel (2–12 mg/day) in adolescent patients (…
evaluated efficacy and safety of adjunctive perampanel (2–12 mg/day) in adolescent patients (…
Delphinidin, a dietary anthocyanidin in berry fruits, inhibits human glyoxalase I
R Takasawa, K Saeki, A Tao, A Yoshimori… - Bioorganic & medicinal …, 2010 - Elsevier
Glyoxalase I (GLO I) is the rate-limiting enzyme for detoxification of methylglyoxal (MG), a
side-product of glycolysis, which is able to induce apoptosis. Since GLO I is known to be highly …
side-product of glycolysis, which is able to induce apoptosis. Since GLO I is known to be highly …
Malignant lymphoma of the uterus. Report of seven cases with immunohistochemical study
K Aozasa, K Saeki, M Ohsawa, K Horiuchi, K Mishima… - Cancer, 1993 - Wiley Online Library
Background. Uterine lymphoma is a rare disease; therefore, information regarding histologic
type, immunophenotype of tumor cells, and etiologic factors are limited. Methods. Seven …
type, immunophenotype of tumor cells, and etiologic factors are limited. Methods. Seven …
Malignant Lymphoma of the Breast: Immunologic Type and Association with Lymphocytic Mastopathy
K Aozasa, M Ohsawa, K Saeki… - American journal of …, 1992 - academic.oup.com
Clinical and pathologic findings in 19 cases of primary non-Hodgkin’s lymphoma of the
breast collected from several hospitals in Japan were reviewed. All patients were women (…
breast collected from several hospitals in Japan were reviewed. All patients were women (…
Discovery of a new type inhibitor of human glyoxalase I by myricetin-based 4-point pharmacophore
R Takasawa, A Tao, K Saeki, N Shionozaki… - Bioorganic & medicinal …, 2011 - Elsevier
The human glyoxalase I (hGLO I), which is a rate-limiting enzyme in the pathway for detoxification
of apoptosis-inducible methylglyoxal (MG), has been expected as an attractive target …
of apoptosis-inducible methylglyoxal (MG), has been expected as an attractive target …
Glycogen synthase kinase-3β2 has lower phosphorylation activity to tau than glycogen synthase kinase-3β1
K Saeki, M Machida, Y Kinoshita… - Biological and …, 2011 - jstage.jst.go.jp
MATERIALS AND METHODS Materials The mouse anti-total-tau (TAU-5), and rabbit anti-phospho-tau
(Ser396) antibodies were purchased from Biosource International (Camarillo, CA, …
(Ser396) antibodies were purchased from Biosource International (Camarillo, CA, …
Structural insights into the hot spot amino acid residues of mushroom tyrosinase for the bindings of thujaplicins
S Takahashi, T Kamiya, K Saeki, T Nezu… - Bioorganic & medicinal …, 2010 - Elsevier
Tyrosinase inhibitors are important agents for cosmetic products. We examined here the
inhibitory effects of three isomers of thujaplicins (α, β and γ) on mushroom tyrosinase and …
inhibitory effects of three isomers of thujaplicins (α, β and γ) on mushroom tyrosinase and …
[HTML][HTML] Long-term tolerability, safety and efficacy of adjunctive perampanel in the open-label, dose-ascending Study 231 and extension Study 233 in Japanese …
…, A Ohnishi, S Kaneko, H Hiramatsu, K Saeki… - Seizure, 2018 - Elsevier
Purpose To evaluate long-term tolerability, safety and efficacy of adjunctive perampanel in a
Phase II, multicentre, open-label, dose-ascending Study 231 (NCT00849212) and its …
Phase II, multicentre, open-label, dose-ascending Study 231 (NCT00849212) and its …